High-dose inhaled terbutaline in the management of chronic severe asthma: comparison of wet nebulisation and tube-spacer delivery.
Authors:
- J G PriorJPJ G Prior
- R V NowellRNR V Nowell
- G M CochraneGCG M Cochrane
Open Access
Abstract
Eight patients with chronic severe asthma, poorly controlled by conventional doses of inhaled bronchodilator, were treated with high-dose inhaled terbutaline (4 mg four times daily), via either wet nebulisation of terbutaline respirator solution, or by tube-spacer aerosol, using cannisters delivering 1 mg terbutaline per metered dose. All patients improved objectively and subjectively on these higher dosage regimens during both day and night. A trial of high-dose inhaled beta2 sympathomimetic therapy should be considered in any patient with chronic severe asthma who fails to obtain benefit from standard doses of inhaled bronchodilator.Keywords
This publication has 7 references indexed in Scilit:
- An objective assessment of the tube spacer in patients unable to use a conventional pressurized aerosol efficientlyRespiratory Medicine, 1981
- INFLUENCE OF TUBE-SPACER ON AEROSOL EFFICACYThe Lancet, 1980
- Home-Monitoring of Peak Expiratory Flow Rate using Mini-Wright Peak Flow Meter in Diagnosis of Asthma1Journal of the Royal Society of Medicine, 1980
- Aerosol salbutamol administration by IPPB: lowest effective dose.Thorax, 1978
- NEBULISED SALBUTAMOL IN ADULT ASTHMAThe Lancet, 1978
- INHALED DRUGS IN PREVENTION OF ASTHMA1977
- Observations on recent increase in mortality from asthma.BMJ, 1968